의료기기관련기관/국가임상시험지원재단
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 05.12(금)
toucrew
2023. 8. 18. 15:17
반응형
Global Data Intelligence Center | ||
구분 | 보고서 (영문) | 업로드 날짜 |
제약/바이오/ 임상시험 |
Merck Bets Big on PRA023 and Inflammatory Bowel Diseases With $10.8B Prometheus Acquisition Offer | 04-28-2023 |
NICE Recommends First Treatment for Incurable Cervical Cancer in 14 Years |
04-27-2023 | |
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Colombia |
04-27-2023 |
|
AZ to Terminate Once-Daily Cotadutide Program to Focus on Weekly GLP-1RA Co-Agonist |
04-25-2023 | |
As Cytokinetics’s ALS Drug Fails Phase III Trial, Attention Turns to Cardiomyopathy Candidate |
04-24-2023 | |
FDA Has Pushed Back on Approving Mirikizumab Due to Manufacturing Issues |
04-20-2023 | |
OncoSec’s Tavo Reaches Tipping Point with Latest Phase IIb Results |
04-20-2023 | |
Moderna Announces Development of New Treatments for Lyme Disease |
04-20-2023 | |
Bristol Myers Squibb’s Blockbuster Sotyktu Scores European Nod for Plaque Psoriasis | 04-20-2023 | |
질환별 |
Melanoma: Cell & Gene Therapies 15-Market Assessment and Forecast |
04-28-2023 |
Body Dysmorphic Disorder: Competitive Landscape |
04-27-2023 | |
Allergic Conjunctivitis: Competitive Landscape |
04-21-2023 | |
Idiopathic Pulmonary Fibrosis: Competitive Landscape |
04-20-2023 | |
컨퍼런스/ 심포지엄/ 학회 등 |
AAN 2023: Importance of Education for Levodopa Infusions in Parkinson’s |
04-26-2023 |
AAN 2023: AbbVie Highlights Qulipta’s Edge over Oral Migraine Prophylaxis |
04-26-2023 | |
AAN 2023: Amneal’s IPX203 Shows Promise for Parkinson’s Disease Patients |
04-26-2023 | |
Highlights from AACR 2023: KRAS Inhibitor Pipeline Candidates Gain Momentum |
04-26-2023 | |
AACR 2023: TRAVERSE - First-in-Human Trial of Allogeneic Anti-CD70 CAR-T Candidate Shows Promise for Advanced Renal Cell Carcinoma |
04-24-2023 | |
ECCMID 2023: Highlights on findings for viral, bacterial, and fungal infections in 2022 |
04-21-2023 | |
ECCMID 2023: Updating the Global Bacterial Priority Pathogens List |
04-21-2023 |
반응형